Skip to main content
CalciMedica, Inc. logo

CalciMedica, Inc. — Investor Relations & Filings

Ticker · CALC ISIN · US38942Q2021 US Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2020-12-10 Director's Dealing
Country US United States of America
Listing US CALC

About CalciMedica, Inc.

https://calcimedica.com/

CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for acute inflammatory and immunologic diseases. The company specializes in the inhibition of calcium release-activated calcium (CRAC) channels, a therapeutic approach designed to modulate the immune response and protect against tissue cell injury. Its lead product candidate, Auxora™, is an intravenous formulation of the proprietary small molecule CRAC channel inhibitor, zegocractin. CalciMedica is developing Auxora for the treatment of life-threatening conditions with high unmet medical needs, including acute kidney injury (AKI) with respiratory failure and acute pancreatitis (AP), for which there are currently no approved disease-modifying treatments.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2020-12-10 English
FORM 4 SUBMISSION
Director's Dealing
2020-12-10 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-20 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes references to Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating it is reporting material information about financial results or condition. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), but rather a current report announcing results or events. The presence of a press release as an exhibit further supports this. Therefore, the document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes Form 8-K filings.
2020-11-12 English
10-Q
Interim / Quarterly Report 9M 2020
2020-11-12 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-10 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.